Jaesh M. Naik
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.
Journal: Future oncology (London, England)
Published: May 19, 2025
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: May 16, 2023
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden.
Journal: Applied health economics and health policy
Published: March 26, 2023
Cost-effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia.
Journal: Journal of comparative effectiveness research
Published: January 23, 2023
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Journal: Infectious diseases and therapy
Published: June 24, 2022
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Journal: Infectious diseases and therapy
Published: November 08, 2021
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Journal: Infectious diseases and therapy
Published: February 02, 2021
Isothermal relaxation kinetics for the reduction and oxidation of SrFeO3 based perovskites.
Journal: Physical chemistry chemical physics : PCCP
Published: January 16, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026